The U.S. Food and Drug Administration (FDA) has awarded fast-track designation — a status that aims to speed the development of promising treatments for serious conditions — to a Swiss biopharmaceutical company for an experimental vaccine designed to slow or prevent neurodegeneration in people with early Parkinson’s disease. The…

While my family and I discussed medication schedules, doctor appointments, and what foods might work best with my uncle Brandon’s Parkinson’s disease, he sometimes had a much more pressing question: “What’s for breakfast?” Usually, the question came with a smirk and his famous cackle, as if to remind us…

I was diagnosed with Parkinson’s disease in 2019 at the age of 55, after my wife noticed a tremor in my left hand. Like many people, I left my doctor’s appointment with more questions than answers. My instinct was to try to maintain a sense of normalcy by following…

People with early Parkinson’s disease who received the oral therapy bezisterim in a Phase 2 clinical trial saw significant improvements in a measure of symptom severity compared with patients given a placebo, top-line results showed. Trial results also showed that bezisterim was generally tolerated well and that the therapy…

The months that followed my diagnosis of Parkinson’s disease were heavy and painful for both my head and my heart. My body had malfunctioned catastrophically, and my mind was suddenly expected to process the enormous emotional fallout. Every day seemed to bring another loss, another fear, another question I…